Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two‐center experience
Objective Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are avai...
Saved in:
Published in | International journal of gynecology and obstetrics Vol. 159; no. 1; pp. 79 - 85 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are available in the literature. We aimed to assess oncologic outcomes of the conservative treatment of APA.
Methods
A multicenter observational retrospective cohort study was performed including all patients with APA who underwent conservative treatment from January 2006 to June 2020. Rates of each oncologic outcome (i.e. initial complete response, persistence, progression to cancer, recurrence, long‐term treatment success, and treatment failure) were calculated for all conservative treatment together and separately.
Results
Twenty‐five patients were included. Conservative treatments consisted of HR alone (n = 14) and HR + progestin (n = 11). Overall, 24 (96%) patients showed initial complete response, of which 21 (84%) showed long‐term treatment success; four (16%) patients had progression to cancer, of which two (8%) first recurred as APA. Long‐term treatment success was achieved in 13 of 14 (92.9%) patients with HR alone and 8 of 11 (72.3%) with HR + progestin.
Conclusion
Conservative treatment appears to be a safe option in women with APA. The four‐steps HR might be considered as the first‐line conservative approach, while the addition of progestin does not seem to improve oncologic outcomes. However, the risk of progression to cancer highlights the need for a close and long‐term follow up with ultrasonography and hysteroscopic biopsies, and for hysterectomy in patients not desiring pregnancy.
Conservative treatment appears safe in women with APA; four‐step HR might be a first‐line conservative approach, while adding progestins seems to not improve oncologic outcomes. |
---|---|
AbstractList | Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are available in the literature. We aimed to assess oncologic outcomes of the conservative treatment of APA.
A multicenter observational retrospective cohort study was performed including all patients with APA who underwent conservative treatment from January 2006 to June 2020. Rates of each oncologic outcome (i.e. initial complete response, persistence, progression to cancer, recurrence, long-term treatment success, and treatment failure) were calculated for all conservative treatment together and separately.
Twenty-five patients were included. Conservative treatments consisted of HR alone (n = 14) and HR + progestin (n = 11). Overall, 24 (96%) patients showed initial complete response, of which 21 (84%) showed long-term treatment success; four (16%) patients had progression to cancer, of which two (8%) first recurred as APA. Long-term treatment success was achieved in 13 of 14 (92.9%) patients with HR alone and 8 of 11 (72.3%) with HR + progestin.
Conservative treatment appears to be a safe option in women with APA. The four-steps HR might be considered as the first-line conservative approach, while the addition of progestin does not seem to improve oncologic outcomes. However, the risk of progression to cancer highlights the need for a close and long-term follow up with ultrasonography and hysteroscopic biopsies, and for hysterectomy in patients not desiring pregnancy. OBJECTIVEAtypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are available in the literature. We aimed to assess oncologic outcomes of the conservative treatment of APA. METHODSA multicenter observational retrospective cohort study was performed including all patients with APA who underwent conservative treatment from January 2006 to June 2020. Rates of each oncologic outcome (i.e. initial complete response, persistence, progression to cancer, recurrence, long-term treatment success, and treatment failure) were calculated for all conservative treatment together and separately. RESULTSTwenty-five patients were included. Conservative treatments consisted of HR alone (n = 14) and HR + progestin (n = 11). Overall, 24 (96%) patients showed initial complete response, of which 21 (84%) showed long-term treatment success; four (16%) patients had progression to cancer, of which two (8%) first recurred as APA. Long-term treatment success was achieved in 13 of 14 (92.9%) patients with HR alone and 8 of 11 (72.3%) with HR + progestin. CONCLUSIONConservative treatment appears to be a safe option in women with APA. The four-steps HR might be considered as the first-line conservative approach, while the addition of progestin does not seem to improve oncologic outcomes. However, the risk of progression to cancer highlights the need for a close and long-term follow up with ultrasonography and hysteroscopic biopsies, and for hysterectomy in patients not desiring pregnancy. Abstract Objective Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are available in the literature. We aimed to assess oncologic outcomes of the conservative treatment of APA. Methods A multicenter observational retrospective cohort study was performed including all patients with APA who underwent conservative treatment from January 2006 to June 2020. Rates of each oncologic outcome (i.e. initial complete response, persistence, progression to cancer, recurrence, long‐term treatment success, and treatment failure) were calculated for all conservative treatment together and separately. Results Twenty‐five patients were included. Conservative treatments consisted of HR alone ( n = 14) and HR + progestin ( n = 11). Overall, 24 (96%) patients showed initial complete response, of which 21 (84%) showed long‐term treatment success; four (16%) patients had progression to cancer, of which two (8%) first recurred as APA. Long‐term treatment success was achieved in 13 of 14 (92.9%) patients with HR alone and 8 of 11 (72.3%) with HR + progestin. Conclusion Conservative treatment appears to be a safe option in women with APA. The four‐steps HR might be considered as the first‐line conservative approach, while the addition of progestin does not seem to improve oncologic outcomes. However, the risk of progression to cancer highlights the need for a close and long‐term follow up with ultrasonography and hysteroscopic biopsies, and for hysterectomy in patients not desiring pregnancy. Conservative treatment appears safe in women with APA; four‐step HR might be a first‐line conservative approach, while adding progestins seems to not improve oncologic outcomes. Objective Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic resection (HR) has showed promising results, the conservative management of APA in young women is not standardized, and few data are available in the literature. We aimed to assess oncologic outcomes of the conservative treatment of APA. Methods A multicenter observational retrospective cohort study was performed including all patients with APA who underwent conservative treatment from January 2006 to June 2020. Rates of each oncologic outcome (i.e. initial complete response, persistence, progression to cancer, recurrence, long‐term treatment success, and treatment failure) were calculated for all conservative treatment together and separately. Results Twenty‐five patients were included. Conservative treatments consisted of HR alone (n = 14) and HR + progestin (n = 11). Overall, 24 (96%) patients showed initial complete response, of which 21 (84%) showed long‐term treatment success; four (16%) patients had progression to cancer, of which two (8%) first recurred as APA. Long‐term treatment success was achieved in 13 of 14 (92.9%) patients with HR alone and 8 of 11 (72.3%) with HR + progestin. Conclusion Conservative treatment appears to be a safe option in women with APA. The four‐steps HR might be considered as the first‐line conservative approach, while the addition of progestin does not seem to improve oncologic outcomes. However, the risk of progression to cancer highlights the need for a close and long‐term follow up with ultrasonography and hysteroscopic biopsies, and for hysterectomy in patients not desiring pregnancy. Conservative treatment appears safe in women with APA; four‐step HR might be a first‐line conservative approach, while adding progestins seems to not improve oncologic outcomes. |
Author | Travaglino, Antonio Insabato, Luigi Seracchioli, Renato Raimondo, Diego Casadio, Paolo Armano, Giulia Raffone, Antonio Zizolfi, Brunella Di Spiezio Sardo, Attilio Buonaiuto, Roberto Mollo, Antonio |
Author_xml | – sequence: 1 givenname: Paolo surname: Casadio fullname: Casadio, Paolo organization: University of Bologna – sequence: 2 givenname: Antonio orcidid: 0000-0001-5443-2333 surname: Raffone fullname: Raffone, Antonio email: anton.raffone@gmail.com, antonio.raffone2@unibo.it organization: University of Naples Federico II – sequence: 3 givenname: Antonio surname: Travaglino fullname: Travaglino, Antonio email: antonio.travaglino.ap@gmail.com, antonio.travaglino@unina.it organization: University of Naples Federico II – sequence: 4 givenname: Diego surname: Raimondo fullname: Raimondo, Diego organization: University of Bologna – sequence: 5 givenname: Brunella surname: Zizolfi fullname: Zizolfi, Brunella organization: University of Naples Federico II – sequence: 6 givenname: Giulia surname: Armano fullname: Armano, Giulia organization: University of Parma – sequence: 7 givenname: Roberto surname: Buonaiuto fullname: Buonaiuto, Roberto organization: University of Naples Federico II – sequence: 8 givenname: Luigi surname: Insabato fullname: Insabato, Luigi organization: University of Naples Federico II – sequence: 9 givenname: Antonio surname: Mollo fullname: Mollo, Antonio organization: University of Salerno – sequence: 10 givenname: Renato surname: Seracchioli fullname: Seracchioli, Renato organization: University of Bologna – sequence: 11 givenname: Attilio surname: Di Spiezio Sardo fullname: Di Spiezio Sardo, Attilio organization: University of Naples Federico II |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34921691$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1O7DAURi0EguGnYQHIJUIKXDuZxKZDiMePkKaBOnKcazBK4mA7QDqW8NbISsgwQEnl4jv3SD7bZL1zHRKyz-CYAfAT-_TgjlkGRbFGZkwUMkmzQq6T2TRCUnDJt8h2CE8AwArGNslWmknOcslmZFh02jXuwWrqhqhdi4E6Q7XrAvoXFe0L0uhRxRa7uFxUHHurVUN714y9szVVNXauHV2rlnt8RDpE9EM4pWc0vrqP9_96ukVP8a1Hb7HTuEs2jGoC7n2_O-T-38Xd-VVyu7i8Pj-7TXTKZZHMJeRKGGFUVhvONdRSQKVBSaXTAvI8E9O3My2EAVMh5Hwuq7kwWtQpk1We7pDDlbf37nnAEMvWBo1Nozp0Qyh5zlg-T6WECT1aodq7EDyasve2VX4sGZTLzOUyc_mVeYIPvr1D1WL9i_50nQC2Al5tg-MfqvL65nKxkn4COF-MsQ |
CitedBy_id | crossref_primary_10_3389_fonc_2024_1386931 crossref_primary_10_3390_cancers16071315 |
Cites_doi | 10.1038/modpathol.2015.137 10.1111/j.1365-2559.1995.tb00288.x 10.1097/PAI.0000000000000780 10.1093/jjco/hyx193 10.3390/cancers12123571 10.1097/PAS.0000000000001320 10.1016/j.ejogrb.2017.05.017 10.3802/jgo.2019.30.e62 10.1007/s00404-012-2355-x 10.1038/modpathol.2008.146 10.1016/j.jmig.2018.07.001 10.1136/jcp.2010.085555 10.1111/jog.13527 10.1097/00000478-199601000-00001 10.1136/jcp.2005.029702 10.1097/MD.0000000000010135 10.1097/PAS.0000000000000428 10.1097/PGP.0b013e3181efbe29 10.1016/S0046-8177(03)00246-6 10.1080/09513590.2019.1696304 10.1016/j.jmig.2017.08.659 10.1016/j.fertnstert.2007.02.061 10.18632/oncotarget.17588 10.1097/00000478-198107000-00006 10.1053/j.semdp.2010.09.007 10.3109/09513590.2013.777418 10.1016/j.humpath.2013.06.020 10.1097/MD.0000000000008034 10.1007/s00404-015-3824-9 10.1016/j.ygyno.2012.12.040 10.3802/jgo.2020.31.e74 10.1111/aogs.13553 10.1111/j.1525-1438.2005.00162.x 10.7326/0003-4819-147-8-200710160-00010 10.1634/theoncologist.2017-0285 10.1111/j.1365-2559.2005.02315.x 10.1016/j.humpath.2008.02.006 10.1093/ajcp/86.2.139 |
ContentType | Journal Article |
Copyright | 2021 International Federation of Gynecology and Obstetrics 2021 International Federation of Gynecology and Obstetrics. |
Copyright_xml | – notice: 2021 International Federation of Gynecology and Obstetrics – notice: 2021 International Federation of Gynecology and Obstetrics. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1002/ijgo.14077 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-3479 |
EndPage | 85 |
ExternalDocumentID | 10_1002_ijgo_14077 34921691 IJGO14077 |
Genre | article Journal Article |
GroupedDBID | --- --K .55 .~1 0R~ 0SF 1B1 1OB 1OC 1RT 1~. 1~5 29J 33P 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDW AAHHS AAIKJ AALRI AANLZ AAQXK AASGY AAXRX AAXUO AAZKR ABBQC ABCUV ABJNI ABLJU ABMAC ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACIUM ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADEZE ADKYN ADMGS ADMUD ADOZA ADVLN ADZMN ADZOD AEEZP AEIGN AEKER AENEX AEQDE AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AGHFR AGYEJ AHBTC AHHHB AIACR AITUG AITYG AIURR AIWBW AJBDE AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMRAJ AMYDB ASPBG AVWKF AZFZN BFHJK BLXMC BMXJE C45 CS3 DCZOG DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FUBAC G-2 G-Q GBLVA HEC HGLYW HMK HMO HVGLF HZ~ IHE J1W KBYEO LATKE LEEKS LOXES LUTES LYRES M29 M2X M41 MEWTI MO0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N9A NCXOZ O-L O66 O9- OAUVE OVD OZT P-8 P-9 P2W PALCI PC. Q38 R2- RIG RJQFR ROL RPZ SAE SAMSI SCC SDF SDG SDP SEL SES SEW SSZ SUPJJ TEORI WHWMO WIH WIJ WIK WOHZO WUQ WVDHM WXSBR X7M YZZ ZGI ZXP ZZTAW NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3297-5906a8f8fa4df22c0d980bc0a9ac37066481404c88f0fbe06259b58fc8d319b63 |
ISSN | 0020-7292 |
IngestDate | Fri Aug 16 21:18:57 EDT 2024 Fri Aug 23 01:14:22 EDT 2024 Sat Sep 28 08:24:37 EDT 2024 Sat Aug 24 00:58:07 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | levonorgestrel-releasing intrauterine system progestogens atypical polypoid adenomyoma carcinoma hysteroscopy tumor progesterone endometrium fertility-sparing hyperplasia levonorgestrel-releasing intrauterine device |
Language | English |
License | 2021 International Federation of Gynecology and Obstetrics. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3297-5906a8f8fa4df22c0d980bc0a9ac37066481404c88f0fbe06259b58fc8d319b63 |
Notes | Funding information No financial support was received for the present study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5443-2333 |
PMID | 34921691 |
PQID | 2611653990 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2611653990 crossref_primary_10_1002_ijgo_14077 pubmed_primary_34921691 wiley_primary_10_1002_ijgo_14077_IJGO14077 |
PublicationCentury | 2000 |
PublicationDate | October 2022 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: October 2022 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | International journal of gynecology and obstetrics |
PublicationTitleAlternate | Int J Gynaecol Obstet |
PublicationYear | 2022 |
References | 2007; 147 2013; 29 2009; 22 2017; 8 2015; 39 2012; 286 2019; 30 2019; 98 1981; 5 2013; 129 2006; 59 2008; 39 2011; 30 2020; 36 2020; 12 2018; 23 2018; 44 2014; 60 2014; 45 2018; 48 2017; 215 2018; 25 2003; 34 2017; 96 2010; 27 2020; 31 1986; 86 1995; 27 2020 2019; 43 2019; 26 2006; 48 2020; 28 2011; 64 2008; 89 2016; 29 2005; 15 2018; 97 1996; 20 2016; 293 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 WHO Classification of Tumours Editorial Board (e_1_2_8_23_1) 2020 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 Sonoyama A (e_1_2_8_12_1) 2014; 60 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 44 start-page: 323 issue: 2 year: 2018 end-page: 330 article-title: Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy publication-title: J Obstet Gynaecol Res – volume: 39 start-page: 1148 issue: 8 year: 2015 end-page: 1155 article-title: Atypical polypoid adenomyoma of the uterus: an immunohistochemical and molecular study of 21 cases publication-title: Am J Surg Pathol – volume: 8 start-page: 57642 issue: 34 year: 2017 end-page: 57653 article-title: Comparison among fertility‐sparing therapies for well differentiated early‐stage endometrial carcinoma and complex atypical hyperplasia publication-title: Oncotarget – volume: 59 start-page: 801 issue: 8 year: 2006 end-page: 812 article-title: My approach to the interpretation of endometrial biopsies and curettings publication-title: J Clin Pathol – volume: 45 start-page: 33 issue: 1 year: 2014 end-page: 40 article-title: Frequent β‐catenin gene mutations in atypical polypoid adenomyoma of the uterus publication-title: Hum Pathol – volume: 25 start-page: 163 issue: 1 year: 2018 end-page: 169.e1 article-title: Hysteroscopic transcervical resection for atypical polypoid adenomyoma of the uterus: a valid, fertility‐preserving option publication-title: J Minim Invasive Gynecol – volume: 5 start-page: 473 issue: 5 year: 1981 end-page: 482 article-title: Atypical polypoid adenomyomas of the endometrium publication-title: Am J Surg Pathol – volume: 27 start-page: 215 issue: 4 year: 2010 end-page: 225 article-title: Endometrial intraepithelial neoplasia publication-title: Semin Diagn Pathol – volume: 22 start-page: 167 issue: 2 year: 2009 end-page: 174 article-title: Squamous morules are functionally inert elements of premalignant endometrial neoplasia publication-title: Mod Pathol – volume: 28 start-page: 646 issue: 8 year: 2020 end-page: 653 article-title: Immunophenotype of atypical polypoid adenomyoma of the uterus: diagnostic value and insight on pathogenesis publication-title: Appl Immunohistochem Mol Morphol – volume: 31 start-page: e74 issue: 5 year: 2020 article-title: Fertility‐sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter‐Group (GCIG) study publication-title: J Gynecol Oncol – volume: 39 start-page: 1446 issue: 10 year: 2008 end-page: 1453 article-title: CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium publication-title: Hum Pathol – volume: 48 start-page: 609 issue: 5 year: 2006 end-page: 610 article-title: Atypical polypoid adenomyoma: a systematic review of the English literature publication-title: Histopathology – volume: 64 start-page: 97 issue: 2 year: 2011 end-page: 106 article-title: Endometrial metaplasias and reactive changes: a spectrum of altered differentiation publication-title: J Clin Pathol – volume: 286 start-page: 707 issue: 3 year: 2012 end-page: 710 article-title: Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas publication-title: Arch Gynecol Obstet – volume: 23 start-page: 478 issue: 4 year: 2018 end-page: 480 article-title: Fertility‐sparing treatment of endometrial cancer with initial infiltration of myometrium by resectoscopic surgery: a pilot study publication-title: Oncologist – volume: 97 issue: 12 year: 2018 article-title: Management of atypical polypoid adenomyoma of the uterus: a single center's experience publication-title: Medicine – volume: 147 start-page: 573 year: 2007 end-page: 577 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies [published correction appears in Ann Intern Med. 2008;148(2):168] publication-title: Ann Intern Med – volume: 129 start-page: 54 issue: 1 year: 2013 end-page: 57 article-title: Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases publication-title: Gynecol Oncol – volume: 89 start-page: 456.e9 issue: 2 year: 2008 end-page: 456.e12 article-title: Hysteroscopic treatment of atypical polypoid adenomyoma diagnosed incidentally in a young infertile woman publication-title: Fertil Steril – volume: 36 start-page: 460 issue: 5 year: 2020 end-page: 464 article-title: Extensive squamous metaplasia (morulosis) of the endometrium as a clinical and pathological problem: a case report and literature study publication-title: Gynecol Endocrinol – volume: 29 start-page: 623 issue: 7 year: 2013 end-page: 625 article-title: A multiple perspectives on atypical polypoid adenomyoma of uterus publication-title: Gynecol Endocrinol – volume: 27 start-page: 35 issue: 1 year: 1995 end-page: 42 article-title: Atypical polypoid adenomyomas of the uterus publication-title: Histopathology – volume: 34 start-page: 784 issue: 8 year: 2003 end-page: 788 article-title: Molecular pathology of atypical polypoid adenomyoma of the uterus publication-title: Hum Pathol – volume: 30 start-page: e62 issue: 4 year: 2019 article-title: Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study publication-title: J Gynecol Oncol – volume: 293 start-page: 177 issue: 1 year: 2016 end-page: 181 article-title: Long‐term outcomes of fertility‐sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate publication-title: Arch Gynecol Obstet – volume: 15 start-page: 974 issue: 5 year: 2005 end-page: 978 article-title: Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection publication-title: Int J Gynecol Cancer – volume: 96 issue: 37 year: 2017 article-title: Comparison of fertility‐sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta‐analysis and systematic review publication-title: Medicine – volume: 98 start-page: 842 issue: 7 year: 2019 end-page: 855 article-title: Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review publication-title: Acta Obstet Gynecol Scand – volume: 60 start-page: E74 issue: 3 year: 2014 end-page: E77 article-title: Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma publication-title: Kobe J Med Sci – volume: 215 start-page: 1 year: 2017 end-page: 5 article-title: Management of atypical polypoid adenomyomas. A case series publication-title: Eur J Obstet Gynecol Reprod Biol – year: 2020 – volume: 20 start-page: 1 issue: 1 year: 1996 end-page: 20 article-title: Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases publication-title: Am J Surg Pathol – volume: 29 start-page: S78 issue: Suppl 1 year: 2016 end-page: S91 article-title: A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus publication-title: Mod Pathol – volume: 86 start-page: 139 issue: 2 year: 1986 end-page: 145 article-title: Atypical polypoid adenomyoma of the uterus. A report of 27 cases publication-title: Am J Clin Pathol – volume: 26 start-page: 648 issue: 4 year: 2019 end-page: 656 article-title: Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility‐sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study publication-title: J Minim Invasive Gynecol – volume: 30 start-page: 64 issue: 1 year: 2011 end-page: 70 article-title: Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h‐caldesmon publication-title: Int J Gynecol Pathol – volume: 12 start-page: 3571 issue: 12 year: 2020 article-title: Fertility sparing treatment of endometrial cancer with and without initial infiltration of myometrium: a single center experience publication-title: Cancers – volume: 48 start-page: 255 issue: 3 year: 2018 end-page: 258 article-title: Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma publication-title: Jpn J Clin Oncol – volume: 43 start-page: 1526 issue: 11 year: 2019 end-page: 1535 article-title: Stromal p16 expression helps distinguish atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma of the uterus publication-title: Am J Surg Pathol – ident: e_1_2_8_28_1 doi: 10.1038/modpathol.2015.137 – ident: e_1_2_8_17_1 doi: 10.1111/j.1365-2559.1995.tb00288.x – ident: e_1_2_8_3_1 doi: 10.1097/PAI.0000000000000780 – ident: e_1_2_8_16_1 doi: 10.1093/jjco/hyx193 – ident: e_1_2_8_35_1 doi: 10.3390/cancers12123571 – ident: e_1_2_8_31_1 doi: 10.1097/PAS.0000000000001320 – ident: e_1_2_8_19_1 doi: 10.1016/j.ejogrb.2017.05.017 – ident: e_1_2_8_36_1 doi: 10.3802/jgo.2019.30.e62 – ident: e_1_2_8_13_1 doi: 10.1007/s00404-012-2355-x – ident: e_1_2_8_39_1 doi: 10.1038/modpathol.2008.146 – ident: e_1_2_8_25_1 doi: 10.1016/j.jmig.2018.07.001 – ident: e_1_2_8_40_1 doi: 10.1136/jcp.2010.085555 – ident: e_1_2_8_20_1 doi: 10.1111/jog.13527 – ident: e_1_2_8_7_1 doi: 10.1097/00000478-199601000-00001 – ident: e_1_2_8_27_1 doi: 10.1136/jcp.2005.029702 – ident: e_1_2_8_21_1 doi: 10.1097/MD.0000000000010135 – volume: 60 start-page: E74 issue: 3 year: 2014 ident: e_1_2_8_12_1 article-title: Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma publication-title: Kobe J Med Sci contributor: fullname: Sonoyama A – ident: e_1_2_8_10_1 doi: 10.1097/PAS.0000000000000428 – ident: e_1_2_8_30_1 doi: 10.1097/PGP.0b013e3181efbe29 – ident: e_1_2_8_9_1 doi: 10.1016/S0046-8177(03)00246-6 – ident: e_1_2_8_41_1 doi: 10.1080/09513590.2019.1696304 – ident: e_1_2_8_14_1 doi: 10.1016/j.jmig.2017.08.659 – ident: e_1_2_8_26_1 doi: 10.1016/j.fertnstert.2007.02.061 – ident: e_1_2_8_33_1 doi: 10.18632/oncotarget.17588 – ident: e_1_2_8_2_1 doi: 10.1097/00000478-198107000-00006 – ident: e_1_2_8_24_1 doi: 10.1053/j.semdp.2010.09.007 – ident: e_1_2_8_5_1 doi: 10.3109/09513590.2013.777418 – ident: e_1_2_8_11_1 doi: 10.1016/j.humpath.2013.06.020 – ident: e_1_2_8_34_1 doi: 10.1097/MD.0000000000008034 – ident: e_1_2_8_15_1 doi: 10.1007/s00404-015-3824-9 – ident: e_1_2_8_18_1 doi: 10.1016/j.ygyno.2012.12.040 – ident: e_1_2_8_38_1 doi: 10.3802/jgo.2020.31.e74 – ident: e_1_2_8_8_1 doi: 10.1111/aogs.13553 – volume-title: Female Genital Tumours year: 2020 ident: e_1_2_8_23_1 contributor: fullname: WHO Classification of Tumours Editorial Board – ident: e_1_2_8_32_1 doi: 10.1111/j.1525-1438.2005.00162.x – ident: e_1_2_8_22_1 doi: 10.7326/0003-4819-147-8-200710160-00010 – ident: e_1_2_8_37_1 doi: 10.1634/theoncologist.2017-0285 – ident: e_1_2_8_4_1 doi: 10.1111/j.1365-2559.2005.02315.x – ident: e_1_2_8_29_1 doi: 10.1016/j.humpath.2008.02.006 – ident: e_1_2_8_6_1 doi: 10.1093/ajcp/86.2.139 |
SSID | ssj0001711 |
Score | 2.4116938 |
Snippet | Objective
Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although... Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although hysteroscopic... Abstract Objective Atypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although... OBJECTIVEAtypical polypoid adenomyoma (APA) is a rare uterine premalignant lesion mainly occurring in premenopausal and nulliparous women. Although... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 79 |
SubjectTerms | atypical polypoid adenomyoma carcinoma endometrium fertility‐sparing hyperplasia hysteroscopy levonorgestrel‐releasing intrauterine device levonorgestrel‐releasing intrauterine system progesterone progestogens tumor |
Title | Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two‐center experience |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijgo.14077 https://www.ncbi.nlm.nih.gov/pubmed/34921691 https://search.proquest.com/docview/2611653990 |
Volume | 159 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbbDYRcSt_ZvlBpTw1uba0fcm9L-kgT0kBIaG5GkqVlQ9cyWTtl--s7sizbodvS9mKMx7ZA38doJI2-QeiVImEueBx6ChjkhTygHg947gVcJIyHLKa5WdA__hIfnIeHF9HFaFQOspbqir8RPzaeK_kfVOEZ4GpOyf4Dst1P4QHcA75wBYTh-lcYnxTC-q49XVfQgBWQFSZBullqvZaDRHKz4V-tywaUUn9bl3qR7zFwO3q51kvmkgVMiYd6ZQ-sV9-1Z7I35VVbCUA6ilz2CfD9euJAhWK-LqTo5Z00BzKZWgBdBL_PVixfaBvEwov9fpNSul1lNeWNF50FRtVrNoeoWG8wnjLgXJE3pvcLOdfD1QyYCLu8OBiMrAemSeqZ460b_bvVi11czjW4eN8WgBkAXS4bpI3iohEB6se4LvPQmW6hLZKkUTRGW7Oj069H3egdJEHQydiSt31TO2jbfXwzhvllYnJzntMEKmd30O12hoFnli530UgW99D2cZtDcR-tOtZgxxqsFR6yBnesMRbHGuxYg3vWGDuwBlvWvMMz3HMG95x5gM4_fjjbP_Da0huemJI08aLUjxlVVLEwV4QIP0-pz4XPUiamCYSpoVFKCwWlyldc-mYWzSOqBM3Bp_N4-hCNC2DLLsIqhRcESWOugpAlAYuIIJzE0ij9cX86QS9dZ2alVVjJrJY2yUzvZ03vT9AL188ZOECzq8UKqetVRmKjIAVxtj9BjywA3X8cYBP0ukHkDw1knw8_nTR3j3_7mydop-fsUzSurmr5DGLSij9vafQT0P6UTQ |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncologic+outcomes+of+conservative+treatment+of+atypical+polypoid+adenomyoma+of+the+uterus%3A+A+two-center+experience&rft.jtitle=International+journal+of+gynecology+and+obstetrics&rft.au=Casadio%2C+Paolo&rft.au=Raffone%2C+Antonio&rft.au=Travaglino%2C+Antonio&rft.au=Raimondo%2C+Diego&rft.date=2022-10-01&rft.eissn=1879-3479&rft_id=info:doi/10.1002%2Fijgo.14077&rft_id=info%3Apmid%2F34921691&rft.externalDocID=34921691 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7292&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7292&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7292&client=summon |